Takatsuki, Japan

Masaru Tanaka

This inventor holds 1 USPTO granted patent. Top assignee: Japan Tobacco Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaru Tanaka. Retrieved from https://idiyas.com/inventor/masaru-tanaka-p0krjbw0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaru Tanaka: Innovator in Aminopyridine Compounds

Introduction: Masaru Tanaka is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on aminopyridine compounds. His innovative approach has led to advancements in Syk inhibitory activity, which has important implications for therapeutic applications.

Latest Patents: Masaru Tanaka holds a patent for aminopyridine compounds having Syk inhibitory activity. The patent describes a compound represented by a specific general formula, which includes various configurations of carbon and nitrogen atoms. The compound is designed to selectively inhibit Syk, showcasing high efficacy in its activity.

Career Highlights: Tanaka's career is marked by his dedication to research and development in the pharmaceutical industry. He is currently associated with Japan Tobacco Inc., where he continues to explore innovative solutions in drug development.

Collaborations: Throughout his career, Masaru Tanaka has collaborated with esteemed colleagues, including Yoshitoshi Kodama and Satoru Noji. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion: Masaru Tanaka's contributions to the field of medicinal chemistry, particularly through his patent on aminopyridine compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…